FDA approves first genetic test to help identify risk of developing opioid use disorder
Fuente:
Wiley Open Access
Enregistré dans:
| Format: | Artículo Open Access |
|---|---|
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
FDA approves drug to treat neurologic manifestations of Hunter syndrome
Publié: (2026)
Publié: (2026)
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Prescribe for patients with opioid use disorder — with confidence
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
How to help young adults in the opioid and stimulant crisis
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Potential for inflammation biomarkers to identify risk for mental disorders
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Study identifies eight traumatic and ACEs to psychiatric risk across development
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
FDA warns against ultra‐processed food risks to children
Publié: (2025)
Publié: (2025)
FDA facing challenges: GAO
Publié: (2026)
Publié: (2026)
Prescription stimulant prescribing, nonmedical use, and shortages: US FDA research and response
Publié: (2025)
Publié: (2025)
FDA lifts bans on fruit vapes
Publié: (2026)
Publié: (2026)
FDA urges higher naloxone doses in fentanyl era
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
From the FDA: Nicotine pouches can be dangerous to children
Publié: (2025)
Publié: (2025)
Reorganizing the FDA is not a good idea: Former officials
Publié: (2025)
Publié: (2025)
FDA warns against accidental overdose on fentanyl patches by children
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Ob‐gyns respond to recent FDA discussion on SSRIs in pregnancy
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Loneliness in early adolescence associated with increased risk for mental disorders
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Inflammatory proteins during pregnancy increases risk of disorders in children
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Pregnancy and high levels of opioids for pain don't mix
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Assess the family to help the child – and the family
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Smart watch can help sleep
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
FDA requests removal of suicide warnings from two GLP‐1 labels
Publié: (2026)
Publié: (2026)
Transdiagnostic online treatment helpful for emotion dysregulation
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Importance of good sleep in helping prevent subsequent suicidal behaviors
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
GWAS insights can help link genes to pharmacologic treatments
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Treatments needed for young people with stimulant use disorders
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Researchers consider links between genetics and psychosis in teen use of psychedelics
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Study suggests glutamate receptor may help differentiate autism varieties
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Study finds varenicline can help young adults quit vaping
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Dopamine link between psychosis and cannabis use disorder unclear
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Cannabis and first episode psychosis: Which came first?
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Stress disorders increase in college students
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Which comes first — psychopathology or excessive videogaming?
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Experimental, but effective: Noninvasive brain stimulation for various disorders
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
CM management, best treatment for stimulant disorder, still on the ropes
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Psychotic‐like experiences found predictive of half of mental disorders
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Off‐label LAI antipsychotics effective for treating bipolar disorder in teens
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Regardless of victim age, trauma increases depression risk
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Automatic protocols for perinatal drug testing harm the maternal–child relationship
par: Alison Knopf
Publié: (2025)
par: Alison Knopf
Publié: (2025)
Psychopathology risk in mid‐adolescence increased by multiple prenatal adversities
par: Alison Knopf
Publié: (2026)
par: Alison Knopf
Publié: (2026)
Researchers recommend training ED physicians on suicide risks in children and teens
par: Alison Knopf
Publié: (2024)
par: Alison Knopf
Publié: (2024)
Documents similaires
-
FDA approves drug to treat neurologic manifestations of Hunter syndrome
Publié: (2026) -
2024 leucovorin paper retracted, drug pending FDA approval for cerebral folate deficiency
par: Alison Knopf
Publié: (2026) -
Prescribe for patients with opioid use disorder — with confidence
par: Alison Knopf
Publié: (2024) -
How to help young adults in the opioid and stimulant crisis
par: Alison Knopf
Publié: (2025) -
Potential for inflammation biomarkers to identify risk for mental disorders
par: Alison Knopf
Publié: (2024)